Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Cardiofocus, Inc.

Home Clinical Trial Sponsors and OrganizationsCardiofocus, Inc.

Cardiofocus, Inc.

500 Nickerson Rd Ste 500200, Marlborough, Massachusetts, United States

Also known as:

cardiofocus

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

11

1 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

5

45.5%

Phase 3

3

27.3%

Phase 4

2

18.2%

Phase 2

1

9.1%

Trial Status Distribution

Active, not recruiting

1

9.1%

Completed

6

54.5%

Recruiting

2

18.2%

Terminated

2

18.2%

Clinical Trials

Trials sponsored by this organization (11)

Pulmonary Vein Isolation With the Single Shot Endoscopic Ultra-Compliant PFA Balloon for the Treatment of AF

Dec 2024100 participants

Ablation With the PFA System With a Large-Area Focal Catheter for the Treatment of Persistent Atrial Fibrillation

Active, not recruiting

Feb 2023200 participants

HeartLight X3 Endoscopic Ablation System With Excalibur Balloon for Treatment of Symptomatic Persistent AF

Feb 201911 participants

Clinical Study of the HeartLight X3 Endoscopic Ablation System With Excalibur Balloon

Feb 201860 participants

CardioFocus HeartLight Post-Approval Study

Jun 2017250 participants

HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)

Jan 2012405 participants

Post-Market Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CF-EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation

Sep 201020 participants

Post-Market Randomized Trial: Endoscopically- Guided Ablation vs. Radiofrequency Ablation

Dec 200921 participants

Page 1 of 2

Approvals

No approval data available

News

CardioFocus Initiates Clinical Trial of OptiShot Pulsed Field Ablation System for Atrial Fibrillation

- CardioFocus has commenced a clinical trial (VISION AF) evaluating the OptiShot Pulsed Field Ablation (PFA) System for paroxysmal atrial fibrillation treatment. - The OptiShot system features an ultra-compliant balloon for precise pulsed energy delivery and tissue contact during pulmonary vein isolation. - The first-in-human trial aims to enroll up to 50 patients, with a 12-month follow-up to assess the technology's efficacy through remapping procedures. - Early user feedback highlights confidence in the system's design for improved long-term outcomes in atrial fibrillation ablation.

On this page

Overview
Clinical Trials11
Approvals
News1

Back to Organizations